Description
TELMI 80 AMH Tablets 28’s
TELMI 80 AMH is a fixed-dose combination tablet containing Telmisartan 80mg, Amlodipine 5mg, and Hydrochlorothiazide 12.5mg, formulated for the effective management of hypertension (high blood pressure). This comprehensive therapy combines three antihypertensive agents to provide synergistic effects in lowering blood pressure.
-
Telmisartan: An angiotensin II receptor blocker (ARB) that relaxes blood vessels by inhibiting the vasoconstrictor effects of angiotensin II, leading to reduced blood pressure.
-
Amlodipine: A calcium channel blocker (CCB) that dilates blood vessels and reduces the heart’s workload, further aiding in blood pressure reduction.
-
Hydrochlorothiazide: A thiazide diuretic that decreases fluid retention by increasing urine output, contributing to lower blood pressure.
This combination therapy is ideal for patients whose blood pressure is not adequately controlled with monotherapy. The once-daily dosing regimen enhances patient adherence and ensures consistent 24-hour blood pressure management.
Key Benefits:
-
Combines three antihypertensive agents in a single tablet
-
Provides effective, once-daily control of high blood pressure
-
Reduces the risk of cardiovascular events such as heart attack and stroke
-
Suitable for patients requiring combination antihypertensive therapy
Precautions:
-
Not recommended during pregnancy, especially in the second and third trimesters.
-
Use with caution in patients with kidney or liver disorders.
-
Regular monitoring of blood pressure, kidney function, and electrolytes is advised during treatment.
-
Avoid potassium supplements or salt substitutes without medical advice.
Note: Always use under medical supervision. Discontinue use if you experience any adverse reactions and consult your healthcare provider.
Reviews
There are no reviews yet.